Funded by a $5.2 million grant from the Laura and John Arnold Foundation (LJAF), the Institute for Clinical and Economic Review (ICER) today launched a program to transform the way new drugs are evaluated and priced in the United States. Through this program, ICER will produce 15-20 reports over the next two years, many of which will be discussed at the public meetings of ICER’s two core programs, CTAF and the New England Comparative Effectiveness Public Advisory Council (CEPAC).
Providing credible, evidence-based information about medical technologies, treatments, and models of care
The California Technology Assessment Forum (CTAF), a core program of the Institute for Clinical and Economic Review (ICER), reviews objective evidence reports and holds public meetings to develop recommendations for how stakeholders can apply evidence to improve the quality and value of health care.
Sign up to receive email notifications of upcoming CTAF meetings and new assessments. All fields required.